Effects of Valproic Acid Coadministration on Plasma Efavirenz and Lopinavir Concentrations in Human Immunodeficiency Virus-Infected Adults

Valproic acid (VPA) has the potential to benefit patients suffering from human immunodeficiency virus (HIV)-associated cognitive impairment. The purpose of this study was to determine if VPA affects the plasma concentration of efavirenz (EFV) or lopinavir. HIV type 1 (HIV-1)-infected patients receiv...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: DiCenzo, Robert, Peterson, Derick, Cruttenden, Kim, Morse, Gene, Riggs, Garret, Gelbard, Harris, Schifitto, Giovanni
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2004
Materias:
Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC525398/
https://ncbi.nlm.nih.gov/pubmed/15504860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.11.4328-4331.2004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares